Douglas S. Micalizzi, Ph.D.
Affiliations: | 2009 | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Molecular Biology, OncologyGoogle:
"Douglas Micalizzi"Parents
Sign in to add mentor| Heide L. Ford | grad student | 2009 | University of Colorado, Denver | |
| (The role of Transforming Growth Factor-beta and epithelial -to -mesenchymal transition in Six1-induced metastasis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mishra A, Huang SB, Dubash T, et al. (2025) Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product. Nature Communications. 16: 32 |
| Brett JO, Dubash TD, Johnson GN, et al. (2023) A Gene Panel Associated With Abemaciclib Utility in -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. Jco Precision Oncology. 7: e2200532 |
| Micalizzi DS, Che D, Nicholson BT, et al. (2022) Targeting breast and pancreatic cancer metastasis using a dual-cadherin antibody. Proceedings of the National Academy of Sciences of the United States of America. 119: e2209563119 |
| Karabacak NM, Zheng Y, Dubash TD, et al. (2022) Differential kinase activity across prostate tumor compartments defines sensitivity to target inhibition. Cancer Research |
| Micalizzi DS, Ebright RY, Haber DA, et al. (2021) Translational Regulation of Cancer Metastasis. Cancer Research |
| Ebright RY, Zachariah MA, Micalizzi DS, et al. (2020) HIF1A signaling selectively supports proliferation of breast cancer in the brain. Nature Communications. 11: 6311 |
| Vidula N, Dubash TD, Lawrence MS, et al. (2020) Identification of somatically acquired BRCA1/2 mutations by cfDNA analysis in patients with metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lee S, Micalizzi D, Truesdell SS, et al. (2020) A post-transcriptional program of chemoresistance by AU-rich elements and TTP in quiescent leukemic cells. Genome Biology. 21: 33 |
| Ebright RY, Lee S, Wittner BS, et al. (2020) Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science (New York, N.Y.) |
| Wander SA, Juric D, Supko JG, et al. (2020) Phase Ib trial to evaluate safety and anti-tumor activity of the AKT inhibitor, ipatasertib, in combination with endocrine therapy and a CDK4/6 inhibitor for patients with hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC) (TAKTIC). Journal of Clinical Oncology. 38: 1066-1066 |